217 related articles for article (PubMed ID: 4526294)
1. [Determination of platelest factor III. (Total content and availability)].
Scrobohaci ML
Med Interna (Bucur); 1974 May; 26(5):623-32. PubMed ID: 4526294
[No Abstract] [Full Text] [Related]
2. Reticulated platelets are increased in chronic myeloproliferative disorders, pure erythrocytosis, reactive thrombocytosis and prior to hematopoietic reconstitution after intensive chemotherapy.
Ryningen A; Apelseth T; Hausken T; Bruserud Ø
Platelets; 2006 Aug; 17(5):296-302. PubMed ID: 16928601
[TBL] [Abstract][Full Text] [Related]
3. [Measurement of platelet factor 3 during central thrombocytopenia].
Sultan Y; Scrobohaci ML; Jaillet N; Caen JP
Nouv Rev Fr Hematol; 1973; 13(4):549-53. PubMed ID: 4271104
[No Abstract] [Full Text] [Related]
4. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
Murphy S; Davis JL; Walsh PN; Gardner FH
Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
[TBL] [Abstract][Full Text] [Related]
5. Stainable blood platelet glycogen in various conditions.
Hermanský F; Hrodek O; Matousová O; Cieslar P
Acta Univ Carol Med Monogr; 1972; 53():165-71. PubMed ID: 4598518
[No Abstract] [Full Text] [Related]
6. Platelet aggregation and platelet factor 3 activity in myeloproliferative disorders.
Tangün Y
Thromb Diath Haemorrh; 1971 Jun; 25(2):241-51. PubMed ID: 5284903
[No Abstract] [Full Text] [Related]
7. Myeloproliferative disorders and platelet functions.
Kubisz P
Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 99(2):202-11. PubMed ID: 4122963
[No Abstract] [Full Text] [Related]
8. Hemoglobin abnormalities in neoplastic hematological disorders.
Walker IR; Ali MA
Can Med Assoc J; 1973 Apr; 108(7):843-7. PubMed ID: 4513360
[TBL] [Abstract][Full Text] [Related]
9. Platelets in myeloproliferative disorders. I. A comparative evaluation with certain platelet function tests.
Boneu B; Nouvel C; Sie P; Caranobe C; Combes D; Laurent G; Pris J; Bierme R
Scand J Haematol; 1980 Sep; 25(3):214-20. PubMed ID: 7466310
[TBL] [Abstract][Full Text] [Related]
10. Kinetics of the blood platelets in myeloproliferative disorders.
Bhattacharya DK
Indian J Cancer; 1975 Jun; 12(2):192-8. PubMed ID: 1058833
[No Abstract] [Full Text] [Related]
11. Platelet function abnormalities in acute leukaemia.
Ramos OF; Morón EC; De Castro Arenas R
Haematologia (Budap); 1981 Dec; 14(4):383-91. PubMed ID: 6954126
[TBL] [Abstract][Full Text] [Related]
12. Qualitative platelet defects with reduced life-span in acute leukaemia.
Van der Weyden MB; Clancy RL; Howard MA; Firkin BG
Aust N Z J Med; 1972 Nov; 2(4):339-45. PubMed ID: 4512369
[No Abstract] [Full Text] [Related]
13. Factors influencing splenic pooling of erythrocytes in the myelo- and lympho-proliferative syndromes.
Toghill PJ; Green S
Acta Haematol; 1973; 49(4):215-22. PubMed ID: 4197946
[No Abstract] [Full Text] [Related]
14. [Blood coagulation and fibrinolysis in chronic myeloproliferative syndromes].
Takahashi K; Shibata A
Rinsho Ketsueki; 1980 May; 21(5):577-86. PubMed ID: 6997548
[No Abstract] [Full Text] [Related]
15. Platelet defects in the myeloproliferative disorders.
Inceman S; Tangün Y
Ann N Y Acad Sci; 1972 Oct; 201():251-61. PubMed ID: 4509685
[No Abstract] [Full Text] [Related]
16. The clinical significance of serum transcobalamins in myeloid leukemia and other myeloproliferative disorders.
Rachmilewitz B; Rachmilewitz M
Isr J Med Sci; 1977 Jul; 13(7):710-5. PubMed ID: 270474
[No Abstract] [Full Text] [Related]
17. [Phospholipids and platelet procoagulant activity in myeloproliferative syndromes].
Martínez E; César J; Navarro JL; Mercado A; Pardo A; García Avello A; García Frade J
Sangre (Barc); 1985; 30(1):22-7. PubMed ID: 4039850
[No Abstract] [Full Text] [Related]
18. [Glycosaminoglycans in leukocytes in myeloproliferative disorders].
Kharchenko MF; Shatskaia TL; Ostroumova SS; Rybakova LP; Shcherbakova EG
Vopr Med Khim; 1984; 30(4):86-91. PubMed ID: 6594825
[TBL] [Abstract][Full Text] [Related]
19. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
[TBL] [Abstract][Full Text] [Related]
20. [Increased hemorrhagic diathesis in acute leukemia].
Petrov MN; Vashkinel' VK
Klin Med (Mosk); 1974 Apr; 52(4):61-5. PubMed ID: 4533307
[No Abstract] [Full Text] [Related]
[Next] [New Search]
